RhumbLine Advisers’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
|
|||||
|
2025
Q1 | $474K | Sell |
|
|||||
|
2024
Q4 | $627K | Buy |
|
|||||
|
2024
Q3 | $528K | Sell |
|
|||||
|
2024
Q2 | $549K | Buy |
|
|||||
|
2024
Q1 | $1.33M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $1.06M | Buy |
|
|||||
|
2023
Q2 | $1.49M | Buy |
|
|||||
|
2023
Q1 | $1.03M | Buy |
|
|||||
|
2022
Q4 | $1.31M | Buy |
|
|||||
|
2022
Q3 | $2.2M | Buy |
|
|||||
|
2022
Q2 | $776K | Buy |
|
|||||
|
2022
Q1 | $844K | Buy |
|
|||||
|
2021
Q4 | $657K | Buy |
|
|||||
|
2021
Q3 | $829K | Buy |
|